- Report
- July 2022
- 96 Pages
Middle East, Africa
From €1430EUR$1,500USD£1,226GBP
- Report
- July 2022
- 94 Pages
Europe
From €1430EUR$1,500USD£1,226GBP
- Report
- July 2022
- 97 Pages
Asia Pacific
From €1430EUR$1,500USD£1,226GBP
- Report
- October 2021
Global
€11914EUR$12,500USD£10,220GBP
- Report
- March 2024
- 122 Pages
Global
From €3500EUR$3,934USD£3,107GBP
- Report
- May 2021
- 112 Pages
Global
From €3200EUR$3,597USD£2,841GBP
- Report
- October 2023
- 146 Pages
Global
From €3362EUR$3,528USD£2,884GBP
€3955EUR$4,150USD£3,393GBP
- Report
- February 2024
- 132 Pages
Global
From €905EUR$950USD£777GBP
- Report
- March 2020
- 108 Pages
Global
From €4289EUR$4,500USD£3,679GBP
High Throughput Screening (HTS) is a technology used in the diagnostics market to rapidly identify compounds that interact with a target of interest. HTS is used to identify potential drug candidates, biomarkers, and other molecules that can be used in diagnostics. It is a powerful tool for drug discovery and development, as it can quickly identify compounds that interact with a target of interest. HTS can also be used to identify potential biomarkers for diagnostics, as it can quickly identify molecules that interact with a target of interest.
HTS is used in a variety of diagnostic applications, including cancer diagnostics, infectious disease diagnostics, and genetic diagnostics. HTS can be used to identify potential drug candidates, biomarkers, and other molecules that can be used in diagnostics.
Some companies in the HTS market include Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, and Thermo Fisher Scientific. Show Less Read more